Search...

⌘K

Try AI Medical Scribe

Save 2+ hours daily with instant clinal dicumentation.

Start Free Trial

GAD-7

Screens and measures severity of generalized anxiety disorder

GAD-7

Screens and measures severity of generalized anxiety disorder

1: Feeling nervous, anxious, or on edge
2: Not being able to stop or control worrying
3: Worrying too much about different things
4: Trouble relaxing
5: Being so restless that it's hard to sit still
6: Becoming easily annoyed or irritable
7: Feeling afraid as if something awful might happen
If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?
GAD-7 0Minimal anxiety
0/8 answered · tap options to update (0–21)

Instructions

The GAD-7 is a brief, self-administered questionnaire used to screen and measure the severity of generalized anxiety disorder. It consists of 7 items scored from 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 21.

Overview
When to use
Why use
Evidences

Interpretation

Score

Anxiety Severity

0–4

Minimal anxiety

5–9

Mild anxiety

10–14

Moderate anxiety

15–21

Severe anxiety

Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD‑7. Arch Intern Med. 2006;166(10):1092–1097. Introduced the 7‑item self‑report scale; at cut‑off ≥10, sensitivity 89% and specificity 82% for GAD in primary care; also demonstrated utility for screening other anxiety disorders.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410326

Löwe B et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD‑7) in the general population. Med Care. 2008;46(3):266–274. Established reliability/validity in a large German sample; provided normative data.
https://journals.lww.com/lww-medicalcare/abstract/2008/03000/validation_and_standardization_of_the_generalized.6.aspx

Kroenke K et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325. Supports use of first two GAD‑7 items (GAD‑2) as a quick screen; positive screens warrant full GAD‑7 and/or diagnostic interview.
https://www.acpjournals.org/doi/10.7326/0003-4819-146-5-200703060-00004 

Overview
When to use
Why use
Evidences

The Generalized Anxiety Disorder-7 (GAD-7) is a validated tool developed for use in primary care and mental health settings to identify and assess anxiety symptoms. It was introduced in 2006 as part of the Patient Health Questionnaire family of instruments and has since become one of the most widely used screening tools for anxiety worldwide.

The GAD-7 evaluates the frequency of seven core anxiety symptoms over the past two weeks, including excessive worry, restlessness, irritability, difficulty relaxing, muscle tension, trouble concentrating, and sleep disturbance. Its brevity and ease of scoring make it practical for routine use by both clinicians and patients.

In addition to generalized anxiety disorder, the GAD-7 has demonstrated utility in screening for other anxiety disorders such as panic disorder, social anxiety disorder, and post-traumatic stress disorder. While not diagnostic on its own, it provides valuable information for initial assessment, treatment planning, and monitoring symptom change over time.

Overview
When to use
Why use
Evidences

Interpretation

Score

Anxiety Severity

0–4

Minimal anxiety

5–9

Mild anxiety

10–14

Moderate anxiety

15–21

Severe anxiety

Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD‑7. Arch Intern Med. 2006;166(10):1092–1097. Introduced the 7‑item self‑report scale; at cut‑off ≥10, sensitivity 89% and specificity 82% for GAD in primary care; also demonstrated utility for screening other anxiety disorders.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410326

Löwe B et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD‑7) in the general population. Med Care. 2008;46(3):266–274. Established reliability/validity in a large German sample; provided normative data.
https://journals.lww.com/lww-medicalcare/abstract/2008/03000/validation_and_standardization_of_the_generalized.6.aspx

Kroenke K et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325. Supports use of first two GAD‑7 items (GAD‑2) as a quick screen; positive screens warrant full GAD‑7 and/or diagnostic interview.
https://www.acpjournals.org/doi/10.7326/0003-4819-146-5-200703060-00004 

Frequently Asked Questions

Features and Services FAQs

Discover the full range of features and services we offer and how to use them.

What does the GAD-7 measure?+
How long does it take to complete?+
What is the scoring range?+
Can the GAD-7 diagnose anxiety disorders?+
How often should it be used?+
Is the GAD-7 valid in different populations?+

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.